Frazier Financial Advisors’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-45
Closed -$767 840
2025
Q4
$767 Hold
45
﹤0.01% 594
2025
Q3
$1.15K Hold
45
﹤0.01% 540
2025
Q2
$2.56K Sell
45
-360
-89% -$28.9K ﹤0.01% 510
2025
Q1
$43.8K Hold
405
0.03% 147
2024
Q4
$19.3K Hold
405
0.02% 256
2024
Q3
$39.7K Sell
405
-71
-15% -$9.17K 0.03% 165
2024
Q2
$77.8K Hold
476
0.06% 112
2024
Q1
$72.6K Hold
476
0.06% 118
2023
Q4
$149K Buy
+476
New +$172K 0.13% 60

Other funds holding AGL

Frazier Financial Advisors's AGL Position: Q1 2026 in Review

Frazier Financial Advisors sold out of Agilon Health (AGL) in Q1 2026, closing a stake of 45 shares — an estimated $767 sold.

Frazier Financial Advisors first reported a position in AGL in Q4 2023 and held it in 9 quarters. The position peaked at $149K in Q4 2023. 97 funds tracked by Wall St. Rank hold AGL as of Q1 2026.

  • Frazier Financial Advisors reported no remaining Agilon Health position as of Q1 2026 after selling out during the quarter.
  • Frazier Financial Advisors sold 45 Agilon Health shares in Q1 2026, an estimated $767.
  • Frazier Financial Advisors first reported a position in Agilon Health in Q4 2023 and held it in 9 quarters.
  • Frazier Financial Advisors's Agilon Health position peaked at $149K in Q4 2023.
  • 97 funds tracked by Wall St. Rank held Agilon Health as of Q1 2026.

Based on Frazier Financial Advisors's 13F filing for Q1 2026, filed 5 May 2026.